Application of RNAi to cancer research and therapy

Frontiers in Bioscience

Volumn 10, Issue 2, 2005, Pages 1946-1960

  Tan, Fischer L ^a,b   Yin, James Q ^a,c  

^a INSTITUTE OF BIOPHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c NONE   (China)

Author keywords

Cancer; miRNAs; Review; RNAi; shRNAs; siRNAs

Indexed keywords

RNA;

ANGIOGENESIS; APOPTOSIS; CANCER RESEARCH; CANCER THERAPY; CELL INVASION; ELECTROPORATION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE TARGETING; GENETIC ANALYSIS; GENETIC SCREENING; GENOMICS; HUMAN; METASTASIS; MOLECULAR DYNAMICS; NONHUMAN; REVIEW; RNA ANALYSIS; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; VIRUS ONCOGENE;

EID: 17244380208     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1670     Document Type: Review

References (155)

1. Vogelstein B. & K. W. Kinzler: Cancer genes and the pathways they control. Nat Med 10 (8), 789-799 (2004)
2. Hahn W. C. & R. A. Weinberg: Modelling the molecular circuitry of cancer. Nat Rev Cancer 2 (5), 331-341 (2002)
3. Wilda M, U. Fuchs, W. Wossmann & A. Borkhardt: Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene 21 (37), 5716-5724 (2002)
4. Hanahan D. & R. A. Weinberg: The hallmarks of cancer. Cell 100 (1), 57-70 (2000)
5. Futreal P. A, L. Coin, M. Marshall, T. Down, T. Hubbard, R. Wooster, N. Rahman & M. R. Stratton: A census of human cancer genes. Nat Rev Cancer 4 (3), 177-183 (2004)
6. Yin J.Q. & Y. Wan: RNA-mediated gene regulation system: now and the future. Int J Mol Med 10 (4), 355-365 (2002)
7. Dorsett Y. & T. Tuschl: siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 3 (4), 318-329 (2004)
8. Bartel D. P: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2), 281-297 (2004)
9. Sharp P. A: RNA interference - 2001. Genes Dev 15 (5), 485-490 (2001)
10. Tan F. L. & J. Q. Yin: RNAi, a new therapeutic strategy against viral infection. Cell Res 14 (6), 460-6 (2004)
11. Dykxhoorn D. M, C. D. Novina & P. A. Sharp: Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Bio 4 (6), 457-467 (2003)
12. Fire A, S. Xu, M. K. Montgomery, S. A. Kostas, S. E. Driver & C. C. Mello: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (6669), 806-811 (1998)
13. Jorgensen R: Altered gene expression in plants due to trans interactions between homologous genes. Trends Biotechnol 8 (12), 340-344 (1990)
14. Williams N. S, R. B. Gaynor, S. Scoggin, U. Verma, T. Gokaslan, C. Simmang, J. Fleming, D. Tavana, E. Frenkel & C. Becerra: Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin Cancer Res 9 (3), 931-946 (2003).
15. Agami R: RNAi and related mechanisms and their potential use for therapy. Curr Opin Chem Bio 6 (6), 829-834 (2002)
16. Brummelkamp T. R. & R. Bernards: New tools for functional mammalian cancer genetics. Nat Rev Cancer 3 (10), 781-789 (2003)
17. Rieber M. & M. Strasberg-Rieber: Induction of tumor cell apoptosis and chemosensitization by antisense strategies. Methods Mol Med 106, 205-214 (2005)
18. Tamm I: Antisense therapy in clinical oncology: preclinical and clinical experiences. Methods Mol Med 106, 113-34 (2005)
19. Geary R. S, T. A. Watanabe, L. Truong, S. Freier, E. A. Lesnik, N. B. Sioufi, H Sasmor, M. Manoharan & A. A. Levin: Pharmacokinetic properties of 2′-O- (2-methoxyethyl)-modified oligonucleotide analogs in rats. J Pharmacol Exp Ther 296 (3), 890-897 (2001)
20. Schubert S. & J. Kurreck: Ribozyme- and deoxyribozyme-strategies for medical applications. Curr Drug Target 5 (8), 667-681 (2004)
21. Citti L, and G. Rainaldi: Synthetic hammerhead ribozymes as therapeutic tools to control disease genes. Curr Gene Ther 5 (1), 11-24 (2005)
22. Lewin A. S. & W. W. Hauswirth: Ribozyme gene therapy: applications for molecular medicine. Trends Mol Med May7 (5), 221-228 (2001)
23. Adah S. A, S. F. Bayly, H. Cramer, R. H. Silverman & P. F. Torrence: Chemistry and biochemistry of 2′,5′-oligoadenylate-based antisense strategy. Curr Med Chem 8 (10), 1189-212 (2001)
24. Xu Z, M. Kuang, J. R. Okicki, H. Cramer & N. Chaudhary: Potent inhibition of respiratory syncytial virus by combination treatment with 2-5A antisense and ribavirin. Antiviral Res 61 (3), 195-206 (2004)
25. Dave R. S. & R. J. Pomerantz: RNA interference: on the road to an alternate therapeutic strategy! Rev Med Virol 13 (6), 373-385 (2003)
26. Elbashir S. M, W. Lendeckel & T. Tuschl: RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15 (2), 188-200 (2001)
27. Elbashir S. M, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber & T. Tuschl: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (6836), 494-498 (2001)
28. Novina C. D. & P. A. Sharp: The RNAi revolution. Nature 430 (696), 161-164 (2004)
29. Soutschek J, A. Akinc, B. Bramlage, K. Charisse, R. Constien, M. Donoghue, S. Elbashir, A. Geick, P. Hadwiger, J. Harborth, M. John, V Kesavan, G Lavine, R. K Pandey, T Racie, K. G. Rajeev, I. Rohl, I. Toudjarska, G. Wang, S. Wuschko, D. Bumcrot, V. Koteliansky, S. Limmer, M. Manoharan & H. P. Vornlocher: Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432 (7014), 173-8 (2004)
30. Paddison P. J, A. A. Caudy, R. Sachidanandam & G. J. Hannon: Short hairpin activated gene silencing in mammalian cells. Methods Mol Biol 265, 85-100 (2004)
31. Tijsterman M. & R. H. Plasterk: Dicers at RISC; the mechanism of RNAi. Cell 117 (1), 1-3 (2004)
32. Carmell M. A. & G. J. Hannon: RNase III enzymes and the initiation of gene silencing. Nat Struct Mol Bio 11 (3), 214-218 (2004)
33. Zhang H, F. A. Kolb, L. Jaskiewicz, E. Westhof & W. Filipowicz: Single processing center models for human Dicer and bacterial RNase III. Cell 118 (1), 57-68 (2004)
34. Martinez J. & T. Tuschl: RISC is a 5′ phosphomonoester- producing RNA endonuclease. Genes Dev 18 (9), 975-980 (2004)
35. Parker J. S, S. M. Roe & D. Barford: Crystal structure of a PIWI protein suggests mechanisms for siRNA recognition and slicer activity. EMBO J. 23 (24), 4727-37 (2004)
36. Rand T. A, K. Ginalski, N. V. Grishin & X. Wang: Biochemical identification of Argonaute 2 as the sole protein required for RNA-induced silencing complex activity. Proc Natl Acad Sci U S A 101 (40), 14385-14389 (2004)
37. Denli A. M, B. B. Tops, R. H. Plasterk, R. F. Ketting & G. J. Hannon: Processing of primary microRNAs by the Microprocessor complex. Nature 432 (7014), 231-235 (2004)
38. Sontheimer E. J. & R. W. Carthew: Molecular biology. Argonaute journeys into the heart of RISC. Science 305 (5689), 1409-1410 (2004)
39. Liu J, M. A. Carmell, F. V. Rivas, C. G. Marsden, J. M. Thomson, J. J. Song, S. M. Hammond, L. Joshua-Tor & G. J. Hannon: Argonaute2 is the catalytic engine of mammalian RNAi. Science 305 (5689), 1437-1441 (2004)
40. Song J. J, S. K. Smith, G. J. Hannon & L. Joshua-Tor: Crystal structure of Argonaute and its implications for RISC slicer activity. Science 305 (5689), 1434-1437 (2004)
41. Okamura K, A. Ishizuka, H. Siomi & M. C. Siomi: Distinct roles for Argonaute proteins in small RNA-directed RNA cleavage pathways. Genes Dev 18 (14), 1655-1666 (2004)
42. Vi R, Y. Qin, I. G. Macara & B. R. Cullen: Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17 (24), 3011-3016 (2003)
43. Zeng Y. & B. R. Cullen: Structural requirements for pre-microRNA binding and nuclear export by Exportin 5. Nucleic Acids Res 32 (16), 4776-4785 (2004)
44. Ambros V: The functions of animal microRNAs. Nature 431 (7006), 350-355 (2004)
45. Krol J, K. Sobczak, U. Wilczynska, M. Drath, A. Jasinska, D. Kaczynska & W. J. Krzyzosiak: Structural features of microRNA (miRNA) precursors and their relevance to miRNA biogenesis and small interfering RNA/short hairpin RNA design. J Biol Chem 279 (40), 42230-42239 (2004)
46. Lee Y, K. Jeon, J. T. Lee, S. Kim & V. N. Kim: MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 21 (17), 4663-4670 (2002)
47. Lai E. C: MicroRNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 30 (4), 363-364 (2002)
48. Doench J. G, C. P. Petersen & P. A Sharp: siRNAs can function as miRNAs. Genes Dev 17 (4), 438-442 (2003)
49. Rajewsky N. & N. D. Socci: Computational identification of microRNA targets. Dev Biol 267 (2), 529-535 (2004)
50. Bartel B. & D. P. Barrel: MicroRNAs: at the root of plant development? Plant Physiol 132 (2), 709-717 (2003)
51. Scherr M. & M. Eder: RNAi in functional genomics. Curr Opin Mol Ther 6 (2), 129-135 (2004)
52. Ge Q, H. N. Eisen & J. Chen: Use of siRNAs to prevent and treat influenza virus infection. Virus Res 102 (1), 37-42 (2004)
53. Lu Q. L, C. J. Mann, F. Lou, G. Bou-Gharios, G. E. Morris, S. A. Xue, S. Fletcher, T. A. Partridge & S. D. Wilton: Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse. Nat Med 9, 1009-1014 (2003)
54. Doudna J. A. & T. R. Cech: The chemical repertoire of natural ribozymes. Nature 418, 222-228 (2002)
55. Braasch D. A. & D. R. Corey: Lipid-mediated introduction of peptide nucleic acids into cells. Biochemistry 41, 4503-4510 (2002)
56. Heasman J: Morpholino oligos: making sense of antisense? Dev Biol 234, 209-214 (2002)
57. Schubert S, D. C. Gul, H. P. Grunert, H. Zeichhardt, V. A. Erdmann & J. Kurreck: RNA cleaving '10-23' DNAzymes with enhanced stability and activity. Nucleic Acids Res 31 (20), 5982-5992 (2003)
58. Carpenter A. E. & D. M. Sabatini: Systematic genome-wide screens of gene function. Nat Rev Genet 5 (1), 11-22 (2004)
59. Brummelkamp T. R, R. Bernards & R. Agami: Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2 (3), 243-247 (2002)
60. Yin J.Q, J. Gao, R. Shao, W.N. Tian, J. Wang & Y. Wan: SiRNA agents inhibit oncogene expression and attenuate human tumor cell growth. J Exp Ther Onc. 3 (4):194-204 (2003)
61. McCaffrey A. P, H. Nakai, K. Pandey, Z. Huang, F. H. Salazar, H. Xu, S. F. Wieland, P. L. Marion & M. A. Kay: Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol 21 (6), 639-644 (2003).
62. Yoshinouchi M, T. Yamada, M. Kizaki, J. Fen, T. Koseki, Y. Ikeda, T. Nishihara & K. Yamato: In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA. Mol The 8 (5), 762-768 (2003).
63. Butz K, T. Ristriani, A. Hengstermann, C. Denk, M. Scheffner & F. Hoppe-Seyler: siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene. 22 (38), 5938-5945 (2003)
64. Dimova D. K, O. Stevaux, M. V. Frolov & N. J. Dyson: Cell cycle-dependent and cell cycle-independent control of transcription by the Drosophila E2F/RB pathway. Genes Dev 17 (18), 2308-2320 (2003)
65. Sancer A, L. A. Lindsey-Boltz, K. Unsal-Kaccmaz & S. Linn: Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73, 39-85 (2004)
66. Peng Y, Q. Zhang, H. Nagasawa, R. Okayasu, H. L. Liber, & J. S. Bedford: Silencing expression of the catalytic subunit of DNA-dependent protein kinase by small interfering RNA sensitizes human cells for radiation-induced chromosome damage, cell killing, and mutation. Cancer Res. 62 (22), 6400-6404 (2002)
67. Takanami T, A. Mori, H. Takahashi, S. Horiuchi & A. Higashitani: Caenorhabditis elegans Ce-rdh-1/rad-51 functions after double-strand break formation of meiotic recombination. Chromosome Res 11 (2), 125-135 (2003)
68. Rinaldo C, P. Bazzicalupo, S. Ederle, M. Milliard & A. La Volpe: Roles for Caenorhabditis elegans rad-51 in meiosis and in resistance to ionizing radiation during development. Genetics 160 (2), 471-479 (2002)
69. Parrish J. Z. & D. Xue: Functional genomic analysis of apoptotic DNA degradation in C. elegans. Mol Cell 11 (4), 987-996 (2003)
70. Lau N. C, L. P. Lim, E. G. Weinstein & D. P. Bartel: An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294 (5543), 858-862 (2001)
71. Pichierri P. & F. Rosselli: The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. EMBO J 23 (5), 1178-1187 (2004).
72. Friedl P. & K. Wolf: Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3 (5), 362-374 (2003).
73. Chen Y, G. Stamatoyannopoulos & C. Z. Song: Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res 63 (16), 4801-4804 (2003)
74. Lakka S. S, C. S. Gondi, N. Yanamandra, W. C. Olivero, D. H Dinh, M. Gujrati & J.S. Rao: Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 23 (27), 4681-4689 (2004)
75. Liu L. T, H. C. Chang, L. C. Chiang & W. C. Hung: Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. Cancer Res 63 (12), 3069-3072 (2003)
76. Bergers G. & L. E. Benjamin: Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3 (6), 401-410 (2003)
77. Niu Q, C. Perruzzi, D. Voskas, J. Lawler, D. J. Dumont & L. E. Benjamin: Inhibition of Tie-2 signaling induces endothelial cell apoptosis, decreases Akt signaling, and induces endothelial cell expression of the endogenous anti-angiogenic molecule, thrombospondin-1. Cancer Biol Ther 3 (4), 402-405 (2004)
78. Schmitt C. A: Senescence, apoptosis and therapy - cutting the lifelines of cancer. Nat Rev Cancer 3 (4), 286-295 (2003)
79. Crnkovic-Mertens I, F. Hoppe-Seyler & K. Butz: Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene. Oncogene 22 (51), 8330-8336 (2003)
80. Lima R. T, L. M. Martins, J. E. Guimaraes, C. Sambade & M. H. Vasconcelos: Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells. Cancer Gene Ther 11 (5), 309-316 (2004)
81. Dudley M. E. & S. A. Rosenberg: Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat Rev Cancer 3 (9), 666-675 (2003)
82. Weissenberger J, S. Loeffler, A. Kappeier, M. Kopf, A. Lukes, T. A. Afanasieva, A. Aguzzi & J. Weis: IL-6 is required for glioma development in a mouse model. Oncogene 23 (19), 3308-3316 (2004)
83. Remy I, A. Montmarquette & S. W. Michnick: PKB/Akt modulates TGF-beta signalling through a direct interaction with Smad3. Nat Cell Biol 6 (4), 358-365 (2004)
84. Mitsiades C. S, N. Mitsiades & M. Koutsilieris: The Akt pathway: molecular targets for anti-cancer drug development. Curr Cancer Drug Targets 4 (3), 235-256 (2004)
85. Gottesman M. M, T. Fojo & S. E. Bates: Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2 (1), 48-58 (2002)
86. Nieth C, A. Priebsch, A. Stege & H. Lage: Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi). FEBS Lett 545 (2-3), 144-150 (2003)
87. Yague E, C. F. Higgins & S. Raguz: Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1. Gene Ther 11 (14), 1170-1174 (2004)
88. Adams J: The proteasome: a suitable antineoplastic target. Nat Rev Cancer 4 (5), 349-360 (2004)
89. Bjornsti M. A. & P. J. Houghton: The TOR pathway: a target for cancer therapy. Nat Rev Cancer 4 (5), 335-348 (2004)
90. Lum L, S. Yao, B. Mozer, A. Rovescalli, D. Von Kessler, M. Nirenberg & P. A. Beachy: Identification of Hedgehog pathway components by RNAi in Drosophila cultured cells. Science 299 (5615), 2039-2045 (2003)
91. Song E, S. K. Lee, J. Wang, N. Ince, N. Ouyang, J. Min, J. Chen, P. Shankar & J. Lieberman: RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 9 (3), 347-351 (2003)
92. Zender L, S. Hutker, C. Liedtke, H. L. Tillmann, S. Zender, B. Mundt, M. Waltemathe, T. Gosling, P. Flemming, N. P. Malek, C. Trautwein, M. P. Manns, F. Kuhnel & S. Kubicka: Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci U S A 100 (13), 7797-7802 (2003)
93. Berns K, E. M. Hijmans, J. Mullenders, T. R. Brummelkamp, A. Velds, M. Heimerikx, R. M. Kerkhoven, M. Madiredjo, W. Nijkamp, B. Weigelt, R. Agami, W. Ge, G. Cavet, P. S. Linsley, R. L. Beijersbergen & R. Bernards: A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428 (6981), 431-437 (2004)
94. Liu T. G, J. Q. Yin, B. Y. Shang, Z. Min, H. W. He, J. M. Jiang, F. Chen, Y. S. Zhen & R. G. Shao: Silencing of hdm2 oncogene by siRNA inhibits p53-dependent human breast cancer. Cancer Gene Ther 11, 748-756 (2004)
95. Lum L. & P. A. Beachy: The Hedgehog response network: sensors, switches, and routers. Science 304 (5678), 1755-1759 (2004)
96. Liu C. G, G. A. Calin, B. Meloon, N. Gamliel, C. Sevignani, M. Ferracin, C. D. Dumitru, M. Shimizu, S. Zupo, M. Dono, H. Alder, F. Bullrich, M. Negrini & C. M. Croce: An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci U S A 101 (26), 9740-9744 (2004)
97. Suyama E, H. Kawasaki, M. Nakajima & K. Taira: Identification of genes involved in cell invasion by using a library of randomized hybrid ribozymes. Proc Natl Acad Sci U S A 100 (10), 5616-5621 (2003)
98. Fraser A. G, R. S. Kamath, P. Zipperlen, M. Martinez-Campos, M. Sohrmann & J. Ahringer: Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 408 (6810), 325-330 (2000)
99. Ashrafi K, F. Y. Chang, J. L. Watts, A. G. Fraser, R. S. Kamath, J. Ahringer & G. Ruvkun: Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 421 (6920), 268-272 (2003)
100. Lee S. S, R. Y. Lee, A. G. Fraser, R. S. Kamath, J. Ahringer & G. Ruvkun: A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nat Genet 33 (1), 40-48 (2003)
101. Pothof J, G. van Haaften, K. Thijssen, R. S. Kamath, A. G. Fraser, J. Ahringer, R. H. Plasterk & M. Tijsterman: Identification of genes that protect the C. elegans genome against mutations by genome-wide RNAi. Genes Dev 17 (4), 443-448 (2003)
102. Brummelkamp T. R, S. M. Nijman, A. M. Dirac & R. Bernards: Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424 (6950), 797-801 (2003)
103. Aza-Blanc P, C. L. Cooper, K. Wagner, S. Batalov, Q. L. Deveraux & M. P. Cooke: Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. Mol Cell 12 (3), 627-637 (2003)
104. Zhou A, S. Scoggin, R. B. Gaynor & N. S. Williams: Identification of NF-kappa B-regulated genes induced by TNFalpha utilizing expression profiling and RNA interference. Oncogene 22 (13), 2054-2064 (2003)
105. Williams N. S, R. B. Gaynor, S. Scoggin, U. Verma, T. Gokaslan, C. Simmang, J. Fleming, D. Tavana, E. Frenkel & C. Becerra: Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin Cancer Res 9 (3), 931-946 (2003)
106. Shoemaker D. D, D. A. Lashkari, D. Morris, M. Mittmann & R. W. Davis: Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar-coding strategy. Nat Gene 14 (4), 450-456 (1996)
107. Paddison P. J. & G. J. Hannon: RNA interference: the new somatic cell genetics? Cancer Cell 2 (1), 17-23 (2002)
108. Fraser A: RNA interference: human genes hit the big screen. Nature 428 (6981), 375-378 (2004)
109. Lagos-Quintana M, R. Rauhut, J. Meyer, A. Borkhardt & T. Tuschl. New microRNAs from mouse and human. RNA 9 (2), 175-179 (2003)
110. Lim L. P, N. C. Lau, E. G. Weinstein, A. Abdelhakim, S. Yekta, M. W. Rhoades, C. B. Burge & D. P. Bartel: The microRNAs of Caenorhabditis elegans. Genes Dev 17 (8), 991-1008 (2003)
111. Lim L. P, M. E. Glasner, S. Yekta, C. B. Burge & D. P. Bartel: Vertebrate microRNA genes. Science 299 (5612), 1540 (2003)
112. Calin G. A, C. D. Dumitru, M. Shimizu, R. Bichi, S. Zupo, E. Noch, H. Aldler, S. Rattan, M. Keating, K. Rai, L. Rassenti, T. Kipps, M. Negrini, F. Bullrich & C. M. Croce: Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99 (24), 15524-15529 (2002)
113. Michael M. Z, S. M. O' Connor, N. G. van Holst Pellekaan, G. F. Young & R. J. James: Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1 (12), 882-891 (2003)
114. Metzler M, M. Wilda, K. Busch, S. Viehmann & A. Borkhardt: High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Concer 39 (2), 167-169 (2004)
115. Calin G. A, C. Sevignani, C. D. Dumitru, T. Hyslop, E. Noch, S. Yendamuri, M. Shimizu, S. Rattan, F. Bullrich, M. Negrini & C. M. Croce: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101 (9), 2999-3004 (2004)
116. Pasquinelli A. E, B. J. Reinhart, F. Slack, M. Q. Martindale, M. I. Kuroda, B. Mailer, D. C. Hayward, E. E. Ball, B. Degnan, P. Muller, J. Spring, A. Srinivasan, M. Fishman, J. Finnerty, J. Corbo, M. Levine, P. Leahy, E. Davidson & G. Ruvkun: Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408 (6808), 86-89 (2000)
117. Ambros V, R. C. Lee, A. Lavanway, P. T. Williams & D. Jewell: MicroRNAs and other tiny endogenous RNAs in C. elegans. Curr Biol 13 (10), 807-818 (2003)
118. Grifftehs-Jones S: The microRNA Registry. Nucleic Acids Res 32, D109-111 (2004)
119. Rhoades M. W, B. J. Reinhart, L. P. Lim, C. B. Burge, B. Bartel & D. P. Bartel: Prediction of plant microRNA targets. Cell 110 (4), 513-520 (2002)
120. Chen X. M: A MicroRNA as a Translational Repressor of APETALA2 in Arabidopsis Flower Development. Science 303 (5666), 2022-2025 (2004)
121. Kiriakidou M, P. T. Nelson, A. Kouranov, P. Fitziev, C. Bouyioukos, Z. Mourelatos & A. Hatzidergiou: A combined computational-experimental approach predicts human microRNA targets. Genes Dev 18 (10), 1165-1178 (2004)
122. Jackson A. L, S. R. Bartz, J. Schelter, S. V. Kobayashi, J. Burchard, M. Mao, B. Li, G. Cavet, P. S. Linsley: Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21 (6), 635-637 (2003)
123. Sledz C. A, M. Holko, M. J. de Veer, R. H. Silverman & B. R. Williams. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 5 (9), 834-839 (2003)
124. Bridge A. J, S. Pebernard, A. Ducraux, A. L. Nicoulaz & R. Iggo. Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet 34 (3), 263-264 (2003)
125. Persengiev S. P, X. C. Zhu and M. R. Green: Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10 (1), 12-18 (2004)
126. Lassus P, J. Rodriguez & Y. Lazebnik, Confirming specificity of RNAi in mammalian cells. Sci STKE (147), PL13 (2002)
127. Smart N, P. J. Scambler & P. R. Riley. A rapid and sensitive assay for quantification of siRNA efficiency and specificity. Biol Proced Online. 7, 1-7 (2005)
128. Bilanges B, & D. Stokoe: Direct comparison of the specificity of gene silencing using antisense and RNAi. Biochem J. [Epub ahead of print] (2005)
129. Huppi K, S. E. Martin, & N. J. Caplen: Defining and assaying RNAi in mammalian cells. Mol Cell 17 (1), 1-10 (2005)
130. S. M. Elbashir, J. Harborth, K. Weber & T. Tuschl: Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26 (2), 199-213 (2002)
131. Reynolds A, D. Leake, Q. Boese, S. Scaringe, W. S. Marshall & A. Khvorova: Rational siRNA design for RNA interference. Nat Biotechnol 22 (3), 326-330 (2004)
132. Cui W, J. Ning, U. P. Naik & M. K. Duncan: OptiRNAi, an RNAi design tool. Comput Methods Programs Biomed 75 (1), 67-73 (2004)
133. Harborth J, S. M. Elbashir, K. Vandenburgh, H. Manninga, S. A. Scaringe, K. Weber & T. Tuschl: Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev 13 (2), 83-105 (2003)
134. Amarzguioui M, T. Holen, E. Babaie & H. Prydz: Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res 31 (2), 589-595 (2003)
135. Czauderna F, M. Fechtner, S. Dames, H. Aygun, A. Klippel, G. J. Pronk, K. Giese & J. Kaufmann: Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res 31 (11), 2705-2716 (2003)
136. Bailey S. N, R. Z. Wu & D. M. Sabatini: Applications of transfected cell microarrays in high-throughput drug discovery. Drug Discov Today 7 (18 Suppl), S113-1118 (2002)
137. Mousses S, N. J. Caplen, R. Cornelison, D. Weaver, M. Basik, S. Hautaniemi, A. G. Elkahloun, R. A. Lotufo, A. Choudary, E. R. Dougherty, E. Suh & O. Kallioniemi: RNAi microarray analysis in cultured mammalian cells. Genome Res 13 (10), 2341-2347 (2003)
138. Silva J. M, H. Mizuno, A. Brady, R. Lucito & G. J. Hannon: RNA interference microarrays: high-throughput loss-of-function genetics in mammalian cells. Proc Natl Acad Sci U S A 101 (17), 6548-6552 (2004)
139. Macarron R: Ultra high quality uHTS. Drug Discov Today 8 (20), 923 (2003)
140. Beasley R. L, P. M. McCoy, T. L. Walker & D. A. Dunn: Miniaturized, ultra-high throughput screening of tyrosine kinases using homogeneous, competitive fluorescence immunoassays. Assay Drug Dev Technol 2 (2), 141-151 (2004)
141. Bai J, R. L. Ramos, J. B. Ackman, A. M. Thomas, R. V. Lee & J. J. LoTurco: RNAi reveals doublecortin is required for radial migration in rat neocortex. Nat Neurosci 6 (12), 1277-1283 (2003)
142. Matsuda T. & C. L. Cepko: Electroporation and RNA interference in the rodent retina in vivo and in vitro. Proc Natl Acad Sci U S A 101 (1), 16-22 (2004)
143. Hommel J. D, R. M. Sears, D. Georgescu, D. L. Simmons & R. J. DiLeone: Local gene knockdown in the brain using viral-mediated RNA interference. Nat Med 9 (12), 1539-1544 (2003)
144. Xia H, Q. Mao, S. L. Eliason, S. Q. Harper, I. H. Martins, H. T. Orr, H. L. Paulson, L. Yang, R. M. Kotin & B. L. Davidson: RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med 10 (8), 816-820 (2004)
145. Lewis D. L, J. E. Hagstrom, A. G. Loomis, J. A. Wolff & H. Herweijer: Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet 32 (1), 107-108 (2002)
146. Wohlbold L, H. van der Kuip, C. Miething, H. P. Vornlocher, C. Knabbe, J. Duyster & W. E.Aulitzky: Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571). Blood 102 (6), 2236-2239 (2003)
147. Cardiff R. D: Mouse models of human breast cancer. Comp Med 53 (3), 250-253 (2003)
148. Hemann M. T, J. S. Fridman, J. T. Zilfou, E. Hernando, P. J. Paddison, C. Cordon-Cardo, G. J. Hannon & S. W. Lowe: An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat Genet 33 (3), 396-400 (2003)
149. Shuey D. J, D. E. McCallus, T. Giordano: RNAi: gene-silencing in therapeutic intervention. Drug Discov Today. 7 (20), 1040-1046 (2002)
150. Lan L, T. Hayashi, R.M. Rabeya, S. Nakajima, S. Kanno, M. Takao, T. Matsunaga, M. Yoshino, M. Ichikawa, H. Riele, S. Tsuchiya, K. Tanaka & A. Yasui: Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis-diamminedichloroplatinum(II) in mammalian cells. DNA Repair (Amst). 3(2), 135-43(2004).
151. Chen J, S. Larochelle, X. Li & B. Suter: Xpd/Ercc2 regulates CAK activity and mitotic progression. Nature 424(6945), 228-232(2003)
152. Nagy P, D.J. Arndt-Jovin & T.M. Jovin: Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1-overexpressing cells. Exp Cell Res 285(1), 39-49(2003)
153. Hung L. & V. Kumar: Specific inhibition of gene expression and transactivation functions of hepatitis B virus X protein and c-myc by small interfering RNAs. FEBS Lett 560(1-3), 210-214(2004)
154. Vassilev L.T, B.T. Vu, B. Graves, D. Carvajal, F. Podlaski, Z. Filipovic, N. Kong U. Kammlott, C. Lukacs, C. Klein, N. Fotouhi & E. A. Liu: In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303(5659), 844-848(2004)
155. Vial E, E. Sahai & C.J. Marshall: ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 4(1), 67-79(2003)